|
1
|
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J,
Shan Z, Liu J, Tian H, Ji Q, et al: China National Diabetes and
Metabolic Disorders Study Group: Prevalence of diabetes among men
and women in China. N Engl J Med. 362:1090–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Konig M, Lamos EM, Stein SA and Davis SN:
An insight into the recent diabetes trials: What is the best
approach to prevent macrovascular and microvascular complications?
Curr Diabetes Rev. 9:371–381. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gajos G, Piłaciński S and
Zozulińska-Ziółkiewicz D: Controversies in diabetes in 2013 - a
brief update. Adv Clin Exp Med. 22:777–784. 2013.
|
|
4
|
Vaz JA and Patnaik A: Diabetes mellitus:
Exploring the challenges in the drug development process. Perspect
Clin Res. 3:109–112. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Diabetes Association: Approaches
to glycemic treatment. Diabetes Care. 38(Suppl 1): S41–48. 2015.
View Article : Google Scholar
|
|
6
|
Sun Y, Fan L, Meng J, Zhang F, Zhang D and
Mei Q: Should GLP-1 receptor agonists be used with caution in high
risk population for colorectal cancer? Med Hypotheses. 82:255–256.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie W, Zhao Y and Zhang Y: Traditional
Chinese medicines in treatment of patients with type 2 diabetes
mellitus. Evid Based Complement Alternat Med. 2011:7267232011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Agyemang K, Han L, Liu E, Zhang Y, Wang T
and Gao X: Recent advances in Astragalus membranaceus antidiabetic
research: Pharmacological effects of its phytochemical
constituents. Evid Based Complement Alternat Med. 2013:6546432013.
View Article : Google Scholar
|
|
9
|
Xie W, Zhao Y and Du L: Emerging
approaches of traditional Chinese medicine formulas for the
treatment of hyperlipidemia. J Ethnopharmacol. 140:345–367. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shih CC, Lin CH, Lin YJ and Wu JB:
Validation of the antidiabetic and hypolipidemic effects of
Hawthorn by assessment of gluconeogenesis and lipogenesis related
genes and AMP-activated protein kinase phosphorylation. Evid Based
Complement Alternat Med. 2013:5970672013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Wang YY and Yang G: Methods and
modes about the theory of traditional Chinese prescription
composition. Zhongguo Zhong Yao Za Zhi. 30:6–8. 112005.In
Chinese.
|
|
12
|
Xie W, Zhao Y, Gu D, Du L, Cai G and Zhang
Y: Scorpion in Combination with Gypsum: Novel Antidiabetic
Activities in Streptozotocin-Induced Diabetic Mice by Up-Regulating
Pancreatic PPARγ and PDX-1 Expressions. Evid Based Complement
Alternat Med. 2011:6835612011. View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Hayes HL, Moss LG, Schisler JC, Haldeman
JM, Zhang Z, Rosenberg PB, Newgard CB and Hohmeier HE: Pdx-1
activates islet α- and β-cell proliferation via a mechanism
regulated by transient receptor potential cation channels 3 and 6
and extracellular signal-regulated kinases 1 and 2. Mol Cell Biol.
33:4017–4029. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Winder WW: AMP-activated protein kinase:
Possible target for treatment of type 2 diabetes. Diabetes Technol
Ther. 2:441–448. 2000. View Article : Google Scholar
|
|
16
|
Zaldumbide A, Carlotti F, Gonçalves MA,
Knaän-Shanzer S, Cramer SJ, Roep BO, Wiertz EJ and Hoeben RC:
Adenoviral vectors stimulate glucagon transcription in human
mesenchymal stem cells expressing pancreatic transcription factors.
PLoS One. 7:e480932012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zou F, Mao XQ, Wang N, Liu J and Ou-Yang
JP: Astragalus polysaccharides alleviates glucose toxicity and
restores glucose homeostasis in diabetic states via activation of
AMPK. Acta Pharmacol Sin. 30:1607–1615. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie W and Du L: Diabetes is an
inflammatory disease: Evidence from traditional Chinese medicines.
Diabetes Obes Metab. 13:289–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu J, Chen X, Zhang Y, Xu J, Zhang L, Li
Z, Liu W, Ouyang J, Han S and He X: Astragalus polysaccharide
induces anti-inflammatory effects dependent on AMPK activity in
palmitate-treated RAW264.7 cells. Int J Mol Med. 31:1463–1470.
2013.PubMed/NCBI
|
|
20
|
Li RJ, Qiu SD, Chen HX, Tian H and Liu GQ:
Effect of Astragalus polysaccharide on pancreatic cell mass in type
1 diabetic mice. Zhongguo Zhong Yao Za Zhi. 32:2169–2173. 2007.In
Chinese.
|
|
21
|
Fu JH, Zheng YQ, Li P, Li XZ, Shang XH and
Liu JX: Hawthorn leaves flavonoids decreases inflammation related
to acute myocardial ischemia/reperfusion in anesthetized dogs. Chin
J Integr Med. 19:582–588. 2013. View Article : Google Scholar
|
|
22
|
Kaneto H, Matsuoka TA, Katakami N and
Matsuhisa M: Combination of MafA, PDX-1 and NeuroD is a useful tool
to efficiently induce insulin-producing surrogate beta-cells. Curr
Med Chem. 16:3144–3151. 2009. View Article : Google Scholar : PubMed/NCBI
|
